Clinical Trial Update: Donepezil to Treat Dementia in Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 study evaluating donepezil for dementia in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED